Quintrio
Home

SERVICES-HOME HEALTH CARE SERVICES

Option Care Health, Inc. Common Stock

OPCH

Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.

Last trade $31.64
Day change -$0.07 (-0.22%)
Day range $31.50 – $31.80
Volume 2,227,736
Market cap $4.75B

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$4.75B
Price / earnings
22.07×
Price / book
3.59×
Price / sales
0.83×
EV / sales
0.98×
EV / EBITDA
13.63×

Profitability

Earnings per share
$1.44
Return on assets
6.19%
Return on equity
16.25%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.87×
Current ratio
1.54×
Quick ratio
1.06×
Cash ratio
0.35×

Cash flow

Price / cash flow
14.75×
Price / free cash flow
16.87×
Free cash flow
$281.65M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for OPCH, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$1.49B$1.44B$1.35B$1.47B$1.44B$1.42B$1.33B$1.35B
Cost of revenue$1.21B$1.18B$1.09B$1.18B$1.16B$1.15B$1.07B$1.08B
Gross profit$284.97M$267.25M$262.01M$282.9M$272.9M$269.04M$263.05M$268.38M
Selling, general and administrative$177.64M$164.66M$174.56M$172.14M$172.1M$170.09M$168.12M$164.73M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$195.76M$182.11M$189.47M$191.4M$188.4M$186.33M$183.86M$181.34M
Operating income$89.22M$85.14M$72.55M$91.5M$84.51M$82.71M$79.19M$87.04M
Interest expense-$12.88M-$14.02M-$13.3M-$12.73M-$14.15M-$14.45M-$13.23M-$10.88M
Income before taxes$78.9M$73.99M$61M$81.52M$68.97M$68.86M$63.56M$81.05M
Income taxes$21.47M$20.07M$15.66M$23.01M$17.15M$18.34M$16.81M$20.92M
Net income$57.43M$53.91M$45.34M$58.5M$51.82M$50.52M$46.74M$60.13M
Net income attributable to common shareholders$57.43M$53.91M$45.34M$58.5M$51.82M$50.52M$46.74M$60.13M
EBITDA$108.05M$103.52M$88.2M$111.82M$101.56M$99.66M$95.56M$104.51M
Basic earnings per share$0.38$0.35$0.29$0.37$0.32$0.31$0.28$0.36
Diluted earnings per share$0.38$0.35$0.29$0.37$0.32$0.31$0.28$0.35

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

BTSG Jumps 11.3% in One Week as Strong Growth Tests Its Valuation

BrightSpring Health Services (BTSG) shares jumped 11.3% following strong Q3 results with revenues up 26.4% to $4.21B and adjusted EPS surging 80%. The company raised its 2026 guidance, but its elevated 30.9X forward P/E valuation leaves limited room for execution errors. While specialty pharmacy growth and margin expansion support the rally, sustained earnings delivery and successful margin conversion remain critical for future gains.

Zacks Investment Research

Addus HomeCare (ADUS) Surpasses Q3 Earnings Estimates

Addus HomeCare reported Q3 2026 earnings of $1.83 per share, beating consensus estimates of $1.78, but revenues of $387.73 million slightly missed expectations. The company has outperformed the market by 17.1% year-to-date. With a Zacks Rank #3 (Hold) rating and mixed estimate revisions, the stock is expected to perform in line with the market. The Medical - Outpatient and Home Healthcare industry ranks in the top 39% of Zacks industries.

Zacks Investment Research

Strength Seen in Option Care (OPCH): Can Its 32.7% Jump Turn into More Strength?

Option Care Health (OPCH) surged 32.7% following the announcement of its acquisition by CD&R and McKesson for $32.05 per share in cash, representing a 37% premium to the previous closing price. The $5.8 billion enterprise value deal underscores the strategic appeal of OPCH's home and alternate-site infusion care platform. However, with unchanged earnings estimate revisions over the past 30 days, analysts caution that sustained momentum may depend on future estimate trends.

Zacks Investment Research

Company News for Oct 7, 2026

Several stocks surged following major announcements: AMD rose 2.8% on plans to boost chip production in 2027 for AI demand. Constellation Energy jumped 12.3% after Google signed a $4.3 billion nuclear power deal. Option Care Health soared 32.7% on acquisition news from McKesson and Clayton, Dubilier & Rice. Vistra Corp. gained 10.8% after the Department of Energy committed $4.2 billion for nuclear facility upgrades.

GlobeNewswire Inc.

Halper Sadeh LLC is Investigating Whether PTC and OPCH are Obtaining Fair Deals for their Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating PTC Inc. and Option Care Health, Inc. for potential violations of federal securities laws and breaches of fiduciary duties relating to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits or terms limiting competing offers are present in these transactions.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Feb 3, 20201-for-4reverse split